Comparison of intensity-modulated radiotherapy with three-dimensional conformal radiation therapy planning for glioblastoma multiforme - PubMed (original) (raw)
Comparative Study
. 2003 Winter;28(4):261-5.
doi: 10.1016/j.meddos.2003.08.004.
Affiliations
- PMID: 14684191
- DOI: 10.1016/j.meddos.2003.08.004
Comparative Study
Comparison of intensity-modulated radiotherapy with three-dimensional conformal radiation therapy planning for glioblastoma multiforme
Maria F Chan et al. Med Dosim. 2003 Winter.
Abstract
This study was designed to assess the feasibility and potential benefit of using intensity-modulated radiotherapy (IMRT) planning for patients newly diagnosed with glioblastoma multiforme (GBM). Five consecutive patients with confirmed histopathologically GBM were entered into the study. These patients were planned and treated with 3-dimensional conformal radiation therapy (3DCRT) using our standard plan of 3 noncoplanar wedged fields. They were then replanned with the IMRT method that included a simultaneous boost to the gross tumor volume (GTV). The dose distributions and dose-volume histograms (DHVs) for the planning treatment volume (PTV), GTV, and the relevant critical structures, as obtained with 3DCRT and IMRT, respectively, were compared. In both the 3DCRT and IMRT plans, 59.4 Gy was delivered to the GTV plus a margin of 2.5 cm, with doses to critical structures below the tolerance threshold. However, with the simultaneous boost in IMRT, a higher tumor dose of approximately 70 Gy could be delivered to the GTV, while still maintaining the uninvolved brain at dose levels of the 3DCRT technique. In addition, our experience indicated that IMRT planning is less labor intensive and time consuming than 3DCRT planning. Our study shows that IMRT planning is feasible and efficient for radiotherapy of GBM. In particular, IMRT can deliver a simultaneous boost to the GTV while better sparing the normal brain and other critical structures.
Similar articles
- Simultaneous modulated accelerated radiation therapy for esophageal cancer: a feasibility study.
Zhang WZ, Chen JZ, Li DR, Chen ZJ, Guo H, Zhuang TT, Li DS, Zhou MZ, Chen CZ. Zhang WZ, et al. World J Gastroenterol. 2014 Oct 14;20(38):13973-80. doi: 10.3748/wjg.v20.i38.13973. World J Gastroenterol. 2014. PMID: 25320535 Free PMC article. - The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: a treatment design study.
Wu Q, Manning M, Schmidt-Ullrich R, Mohan R. Wu Q, et al. Int J Radiat Oncol Biol Phys. 2000 Jan 1;46(1):195-205. doi: 10.1016/s0360-3016(99)00304-1. Int J Radiat Oncol Biol Phys. 2000. PMID: 10656393 - Functional brain imaging interventions for radiation therapy planning in patients with glioblastoma: a systematic review.
Ryan JT, Nakayama M, Gleeson I, Mannion L, Geso M, Kelly J, Ng SP, Hardcastle N. Ryan JT, et al. Radiat Oncol. 2022 Nov 12;17(1):178. doi: 10.1186/s13014-022-02146-8. Radiat Oncol. 2022. PMID: 36371225 Free PMC article. Review.
Cited by
- 3D-CRT versus RapidArc in Deep Tempero-Parietal High Grade Gliomas: Do We Really Need Higher Technology?
Mashhour K, Abdelghany H, Mounir A, Hashem W. Mashhour K, et al. Asian Pac J Cancer Prev. 2022 Jun 28;23(6):2169-2176. doi: 10.31557/APJCP.2022.23.6.2169. Asian Pac J Cancer Prev. 2022. PMID: 35763662 Free PMC article. - Custom-designed mouthpiece for HDR brachytherapy of embryonal rhabdomyosarcoma of the soft palate.
Ekwelundu E, Krasin MJ, Farr JB. Ekwelundu E, et al. J Contemp Brachytherapy. 2014 Oct;6(3):300-3. doi: 10.5114/jcb.2014.44977. Epub 2014 Aug 29. J Contemp Brachytherapy. 2014. PMID: 25337134 Free PMC article. - Sparing of normal tissues with volumetric arc radiation therapy for glioblastoma: single institution clinical experience.
Briere TM, McAleer MF, Levy LB, Yang JN. Briere TM, et al. Radiat Oncol. 2017 May 2;12(1):79. doi: 10.1186/s13014-017-0810-3. Radiat Oncol. 2017. PMID: 28464840 Free PMC article. Clinical Trial. - Comparison of the Effectiveness of Radiotherapy with 3D-CRT, IMRT, VMAT and PT for Newly Diagnosed Glioblastoma: A Bayesian Network Meta-Analysis.
Xu S, Frakulli R, Lin Y. Xu S, et al. Cancers (Basel). 2023 Dec 3;15(23):5698. doi: 10.3390/cancers15235698. Cancers (Basel). 2023. PMID: 38067401 Free PMC article. - Quasi-VMAT in high-grade glioma radiation therapy.
Fadda G, Massazza G, Zucca S, Durzu S, Meleddu G, Possanzini M, Farace P. Fadda G, et al. Strahlenther Onkol. 2013 May;189(5):367-71. doi: 10.1007/s00066-012-0296-8. Epub 2013 Apr 4. Strahlenther Onkol. 2013. PMID: 23549780 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical